Back to search

Article

Exenatide and renal outcomes in patients with type 2 diabetes and diabetic kidney disease: a multi-center, randomized, parallel study

2020-04-30

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>This trial aimed to assess the effects of exenatide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), on renal outcomes in patients with type 2 diabetes mellitus (T2DM) and diabetic kidney disease (DKD).<bold>Methods:</bold> We performed a randomized, parallel study conducted in 4 general hospitals. T2DM patients with an estimated glomerular filtration rate...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
aede0c34-b554-5979-8f24-0325837c7fe1
DOI
10.21203/rs.3.rs-24153/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exenatide and renal outcomes in patients with type 2 diabetes and diabetic kidney disease: a multi-center, randomized, parallel studyDOI 10.21203/rs.3.rs-24153/v1
Renal outcomes of combination therapy with sodium-glucose cotransporter 2 inhibitors plus renin-angiotensin system blockers in patients with type 2 diabetes mellitus: A population-based cohort studySemantic proximity
Diabetic Kidney Disease: Evidence from Two Selected Cohorts of Patients from Low-Middle and High Income CountriesSemantic proximity
Liver Enzymes in End Stage Renal Disease Patients Diabetic and Non- Diabetic. Does it Differ than General Population?Semantic proximity
Diabetic kidney disease phenotypes and the risk of cardiovascular events: The Silesia Diabetes-Heart Project.Semantic proximity
Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in the Very Elderly with Chronic Kidney Disease: a Retrospective Cohort Study Using Real-World DataSemantic proximity
Chronic Kidney Disease in the Elderly Patient with DiabetesSemantic proximity
Kidney outcomes with SGLT2 inhibitors in patients with diabetes and an insulin-deficient phenotype: A real world analysis.Semantic proximity
Association of evaluated glomerular filtration rate and incident diabetes mellitus: a secondary retrospective analysis based on a Chinese Cohort StudySemantic proximity
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetesSemantic proximity
Use of real-world evidence data to evaluate the comparative effectiveness of second-line type 2 diabetes medications on chronic kidney diseaseSemantic proximity
Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes: An Umbrella ReviewSemantic proximity
Expression profile of urinary exosomal miRNAs in patients with diabetic kidney disease and their associated with kidney damageSemantic proximity
Select a neighboring publication to make it the new centre.